These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20403494)

  • 1. Lack of sinus rhythm predicts readmission, not Beta blockade.
    McCulloch AC
    Am J Cardiol; 2010 May; 105(9):1358. PubMed ID: 20403494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
    MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
    [No Abstract]   [Full Text] [Related]  

  • 3. Making sense of SENIORS.
    McMurray J
    Eur Heart J; 2005 Feb; 26(3):203-6. PubMed ID: 15647290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
    MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
    [No Abstract]   [Full Text] [Related]  

  • 5. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta blocker in endothelial dysfunction. Growth of blood vessel cells is halted].
    MMW Fortschr Med; 2002 Aug; 144(33-34):56. PubMed ID: 12380150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta blocker activates release of NO. Radical against atherosclerosis].
    MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152777
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol: new indication. Heart failure: 'me-too' available in single dose strength only. Select better-assessed betablockers.
    Prescrire Int; 2007 Dec; 16(92):235. PubMed ID: 18087800
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
    [No Abstract]   [Full Text] [Related]  

  • 14. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
    Carvalho VO
    Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency].
    Boutelant S; Lechat P; Komajda M; Isnard R; Salloum J; Gagey S; Bertholon JF; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):863-70. PubMed ID: 1358044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability.
    Bilchick KC; Berger RD
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):691-4. PubMed ID: 16836727
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy.
    Mignatti A; Sims DB; Colombo PC; Garcia LI; Bijou R; Deng MC; Jorde UP
    Cardiovasc Ther; 2009; 27(1):42-8. PubMed ID: 19207479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.